Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Primary prophylaxis in haemophilia care : Guideline update 2016

Fischer, Kathelijn and Ljung, Rolf LU orcid (2017) In Blood Cells, Molecules, and Diseases 67. p.81-85
Abstract

This paper reviews the current status on recommendations or guidelines for primary prophylaxis based on recent published papers from organizations or group of experts as well as some original key papers. A rather uniform view exists that prophylaxis should be initiated at an early age before or after no more than a single joint bleed and, if possible, preferably be continued for life. The dose and dose frequency of prophylaxis is dependent on the goal of treatment, bleeding phenotype, compliance, venous access and economic resources in the health care system and should be tailored individually based on clinical outcome and pharmacokinetics. For children, the effectiveness of prophylaxis is more dependent on maintaining minimum trough... (More)

This paper reviews the current status on recommendations or guidelines for primary prophylaxis based on recent published papers from organizations or group of experts as well as some original key papers. A rather uniform view exists that prophylaxis should be initiated at an early age before or after no more than a single joint bleed and, if possible, preferably be continued for life. The dose and dose frequency of prophylaxis is dependent on the goal of treatment, bleeding phenotype, compliance, venous access and economic resources in the health care system and should be tailored individually based on clinical outcome and pharmacokinetics. For children, the effectiveness of prophylaxis is more dependent on maintaining minimum trough levels than in adults. Novel extended half-life products are being introduced, which should not affect the decision on when to start prophylaxis nor the initial dose, but which may be helpful for patients with difficult venous access and which may enable higher trough levels of factor VIII.

(Less)
Please use this url to cite or link to this publication:
author
and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Factor IX, Factor VIII, Haemophilia A, Haemophilia B, Prophylaxis
in
Blood Cells, Molecules, and Diseases
volume
67
pages
81 - 85
publisher
Elsevier
external identifiers
  • scopus:85014835704
  • pmid:28302350
  • wos:000414342200014
ISSN
1079-9796
DOI
10.1016/j.bcmd.2017.02.004
language
English
LU publication?
yes
id
a3727dd7-2947-43d5-b95d-612f3514024d
date added to LUP
2017-04-03 10:19:38
date last changed
2024-10-14 03:32:40
@article{a3727dd7-2947-43d5-b95d-612f3514024d,
  abstract     = {{<p>This paper reviews the current status on recommendations or guidelines for primary prophylaxis based on recent published papers from organizations or group of experts as well as some original key papers. A rather uniform view exists that prophylaxis should be initiated at an early age before or after no more than a single joint bleed and, if possible, preferably be continued for life. The dose and dose frequency of prophylaxis is dependent on the goal of treatment, bleeding phenotype, compliance, venous access and economic resources in the health care system and should be tailored individually based on clinical outcome and pharmacokinetics. For children, the effectiveness of prophylaxis is more dependent on maintaining minimum trough levels than in adults. Novel extended half-life products are being introduced, which should not affect the decision on when to start prophylaxis nor the initial dose, but which may be helpful for patients with difficult venous access and which may enable higher trough levels of factor VIII.</p>}},
  author       = {{Fischer, Kathelijn and Ljung, Rolf}},
  issn         = {{1079-9796}},
  keywords     = {{Factor IX; Factor VIII; Haemophilia A; Haemophilia B; Prophylaxis}},
  language     = {{eng}},
  month        = {{02}},
  pages        = {{81--85}},
  publisher    = {{Elsevier}},
  series       = {{Blood Cells, Molecules, and Diseases}},
  title        = {{Primary prophylaxis in haemophilia care : Guideline update 2016}},
  url          = {{http://dx.doi.org/10.1016/j.bcmd.2017.02.004}},
  doi          = {{10.1016/j.bcmd.2017.02.004}},
  volume       = {{67}},
  year         = {{2017}},
}